June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Prevalence of hypertensive retinopathy and its risk for mortality – results from the Gutenberg Health Study
Author Affiliations & Notes
  • Alexander Karl-Georg Schuster
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Stella Hoh
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Karl Neubert
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Ahmad Haj Ibrahim
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Stefan Nickels
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Christina A. Korb
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Andreas Schulz
    Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center Mainz, Germany
  • Thomas Muenzel
    Center for Cardiology – Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Germany
  • Matthias Michal
    Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Mainz, Germany
  • Irene Schmidtmann
    Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Germany
  • Karl Lackner
    Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Germany
  • Philipp Wild
    Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center Mainz, Germany
  • Norbert Pfeiffer
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Footnotes
    Commercial Relationships   Alexander Schuster, Allergan (F), Bayer Vital (F), Heidelberg Engineering (F), Novartis (F), PlusOptix (F); Stella Hoh, None; Karl Neubert, None; Ahmad Haj Ibrahim, None; Stefan Nickels, None; Christina A. Korb, None; Andreas Schulz, None; Thomas Muenzel, None; Matthias Michal, None; Irene Schmidtmann, None; Karl Lackner, None; Philipp Wild, None; Norbert Pfeiffer, None
  • Footnotes
    Support  Ernst und Berta-Grimmke Foundation
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1308. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexander Karl-Georg Schuster, Stella Hoh, Karl Neubert, Ahmad Haj Ibrahim, Stefan Nickels, Christina A. Korb, Andreas Schulz, Thomas Muenzel, Matthias Michal, Irene Schmidtmann, Karl Lackner, Philipp Wild, Norbert Pfeiffer; Prevalence of hypertensive retinopathy and its risk for mortality – results from the Gutenberg Health Study. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1308.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The evaluation of the retinal vasculature can be used to detect end organ damage and to stratify cardiovascular risk in patients with arterial hypertension. In this study we investigate the relationship between hypertensive retinopathy and mortality in a population-based cohort.

Methods : The Gutenberg Health Study is a population-based study with 15,010 participants aged 35 to 74. An ophthalmological examination was performed including fundus photography. Grading of hypertensive retinopathy signs (focal and generalized arterial narrowing, arteriovenous notching, retinal bleedings, microaneurysms, cotton wool spots, hard exudates, macular edema, papilledema) was conducted at Mainz Ophthalmic Reading Center and classified according to Mitchell-Wong-Classification. Data from the residents' registration offices were used to determine whether and when a study participant had passed away. Age- and sex-weighted prevalence estimators for hypertensive retinopathy in the German population (2014) including 95% confidence intervals (CI) were computed. Using Cox regression analysis, the relationship between hypertensive retinopathy and mortality was analyzed taking classic cardiovascular risk factors (age, sex, smoking, dyslipidemia, arterial hypertension, diabetes, body-mass-index, family history of stroke and myocardial infarction) into account.

Results : 12,751 persons (49.8% female) with an average age of 55.9±11.1 years were included in this analysis. 6.7% (95% CI: 6.3% - 7.2%) had mild and 4.0% (95% CI: 3.7% - 4.4%) moderate hypertensive retinopathy. The median follow-up time was 8.6 years. There was an association between hypertensive retinopathy and mortality, both after adjustment for age and sex (mild: HR=1.24, p=0.06; moderate: HR=1.99, p<0.001; reference: no) and after adjustment for classic cardiovascular risk factors (mild: HR=1.23, p=0.08; moderate: HR=1.75, p<0.001; reference: no).

Conclusions : The prevalence of hypertensive retinopathy is 6.7% for the mild form and 4.0% for the moderate form in the German population at age 35 to 74 years. In particular, the moderate form of hypertensive retinopathy is a risk factor for mortality independent of classic cardiovascular risk factors. Patients with such changes should have a thoughtful general examination and their cardiovascular risk factors should be optimized.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×